Telomir Pharmaceuticals TELO
NASDAQ TELO
$1.02 +0.01 (+0.99%)
At close: Oct 21, 2026 · 4:00 PM EDT

Telomir Pharmaceuticals (TELO) EPS (Basic) (2023 - 2026)

Updated

Telomir Pharmaceuticals' EPS (Basic) came in at -$0.79 for Q2 2026, compared with -$0.17 a year earlier.

Analysis

Telomir Pharmaceuticals (TELO) EPS (Basic) (2023 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Telomir Pharmaceuticals reported EPS (Basic) of -$0.92; for FY2025, it came in at -$0.33.

  • Going back by year, EPS (Basic) was -$0.56 in FY2024, -$0.48 in FY2023 and -$0.03 in FY2022.
  • The Q2 2026 figure represents the lowest quarterly EPS (Basic) in data going back to Q1 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 7.95
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 2.30
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 2.04
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -0.54
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 1.68
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 1.62
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 4.40
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -8.44
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -0.04
10 Telomir Pharmaceuticals 62.66 Mn 42.09 Mn - -0.79
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.79
Dec 31, 2025 -0.06
Sep 30, 2025 -0.03
Jun 30, 2025 -0.17
Mar 31, 2025 -0.07
Dec 31, 2024 -0.10
Sep 30, 2024 -0.20
Jun 30, 2024 -0.05
Mar 31, 2024 -0.23
Dec 31, 2023 -0.34
Sep 30, 2023 -0.06
Jun 30, 2023 -0.06
Mar 31, 2023 -0.02
API Access

Telomir Pharmaceuticals EPS (Basic) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-basic&ticker=TELO&period=max&api_key=YOUR_API_KEY